These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 10096372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA, Ward DM, Lindberg JS, Allen JM, Husserl FE, Marcucci PA, Cole FE, Turnipseed J, Alam J, Kok DJ.
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [Abstract] [Full Text] [Related]

  • 3. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A, Hochreiter W, Jaeger P, Hess B.
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B, Jordi S, Zipperle L, Ettinger E, Giovanoli R.
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index.
    Laube N, Glatz S, Hesse A.
    Urol Res; 2001 Feb; 29(1):45-9. PubMed ID: 11310215
    [Abstract] [Full Text] [Related]

  • 10. Expression of Tamm-Horsfall protein in stone-forming rat models.
    Miyake O, Yoshioka T, Yoshimura K, Honda M, Yamaguchi S, Koide T, Okuyama A.
    Br J Urol; 1998 Jan; 81(1):14-9. PubMed ID: 9467470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V, Kalaiselvi P, Sumitra K, Srinivasan S, Varalakshmi P.
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [Abstract] [Full Text] [Related]

  • 14. Decreased Tamm-Horsfall protein in lithiasic patients.
    Romero MC, Nocera S, Nesse AB.
    Clin Biochem; 1997 Feb; 30(1):63-7. PubMed ID: 9056112
    [Abstract] [Full Text] [Related]

  • 15. Role of urinary inhibitors of crystallization in uric acid nephrolithiasis: Dalmatian dog model.
    Carvalho M, Lulich JP, Osborne CA, Nakagawa Y.
    Urology; 2003 Sep; 62(3):566-70. PubMed ID: 12946778
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone disease.
    Lau WH, Leong WS, Ismail Z, Gam LH.
    Int J Biol Sci; 2008 Aug 04; 4(4):215-22. PubMed ID: 18695745
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
    Tsujihata M, Miyake O, Yoshimura K, Kakimoto K, Takahara S, Okuyama A.
    Eur Urol; 2001 Oct 04; 40(4):458-62. PubMed ID: 11713403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.